Zehan Chen
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Molecular Biology top 10%
- DNA Repair Mechanisms
- Cancer therapeutics and mechanisms
- Cell death mechanisms and regulation
Papers in
-
- DNA Repair Mechanisms 14
- Cancer therapeutics and mechanisms 9
- Cell death mechanisms and regulation 2
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 16
- Cancer-related Molecular Pathways 15
- Co-authors
- Saul H. Rosenberg (16 shared papers)Thomas J. Sowin (13 shared papers)Haiying Zhang (13 shared papers)Zhan Xiao (5 shared papers)Angelo Gunasekera (1 shared paper)Hing L. Sham (10 shared papers)Peter Kovar (14 shared papers)Nan‐Horng Lin (12 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)Neoplasia (2 papers)Journal of Biological Chemistry (2 papers)Journal of Medicinal Chemistry (2 papers)SLAS DISCOVERY (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Zehan Chen
27 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 94
- Oncology 448
- Molecular Biology 1.0k
- Cell Biology 188
- Cancer Research 130
- Toxicology 28
Countries citing papers authored by Zehan Chen
This map shows the geographic impact of Zehan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zehan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zehan Chen more than expected).
Fields of papers citing papers by Zehan Chen
This network shows the impact of papers produced by Zehan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zehan Chen. The network helps show where Zehan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Zehan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 286 | |
| 2 | 1998 | 212 | |
| 3 | 2006 | 103 | |
| 4 | 2011 | 94 | |
| 5 | Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint. | 2003 | 80 |
| 6 | 2007 | 69 | |
| 7 | 2020 | 53 | |
| 8 | 2001 | 40 | |
| 9 | 2001 | 39 | |
| 10 | 2005 | 35 | |
| 11 | 2005 | 35 | |
| 12 | 2005 | 34 | |
| 13 | 2007 | 33 | |
| 14 | 2006 | 29 | |
| 15 | 2007 | 25 | |
| 16 | 2006 | 24 | |
| 17 | 2007 | 22 | |
| 18 | 2007 | 13 | |
| 19 | 1999 | 11 | |
| 20 | 2008 | 10 |
About Zehan Chen
Zehan Chen is a scholar working on Molecular Biology, Oncology, Cell Biology, Computer Vision and Pattern Recognition and Computer Networks and Communications, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (15 papers), DNA Repair Mechanisms (14 papers), Cancer therapeutics and mechanisms (9 papers), Microtubule and mitosis dynamics (5 papers), Advanced Malware Detection Techniques (2 papers), Cancer Mechanisms and Therapy (2 papers), Cell death mechanisms and regulation (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Oncology (448 citations), Molecular Biology (1.0k citations), Cell Biology (188 citations), Cancer Research (130 citations) and Toxicology (28 citations). Zehan Chen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Saul H. Rosenberg, Thomas J. Sowin, Haiying Zhang, Zhan Xiao, Angelo Gunasekera, Hing L. Sham, Peter Kovar, Nan‐Horng Lin, Robert Meadows and Stephen W. Fesik. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Neoplasia, Journal of Biological Chemistry, Journal of Medicinal Chemistry and SLAS DISCOVERY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.